Keyphrases
Anticoagulant Therapy
12%
Antithrombotic Therapy
16%
Apixaban
14%
Aspirin
12%
Bleeding
16%
Bleeding Complications
12%
Carboxylesterase 1 (CES1)
50%
Coagulation Index
8%
Coagulation State
8%
Coagulation System
12%
Complication Risk
12%
Congestive Heart Failure
50%
Dabigatran
42%
Device Complications
33%
Device Type
8%
Direct Oral Anticoagulants
50%
Genetic Polymorphism
100%
Genotype Polymorphism
37%
Healthy Controls
12%
Heart Failure Patients
66%
HeartMate 3
50%
HeartMate II
50%
HeartWare
50%
Hemostasis
12%
High Risk
12%
Individualized Dosing
12%
ITGB3
25%
ITGB3 Gene
16%
Left Ventricular Assist Device
100%
Left Ventricular Assist Device Implantation
20%
Left Ventricular Assist Device Support
12%
Mechanical Circulatory Support
50%
Metabolism
20%
Mortality Rate
12%
Non-valvular Atrial Fibrillation
28%
Physiologic
12%
Platelet Function
8%
Rs1045642
14%
Rs2244613
14%
Rs5918
29%
Rs9923231
20%
Shear Stress
12%
Single nucleotide Polymorphism
12%
SNP
25%
Thromboelastography
16%
Thrombosis
29%
UGT1A6
25%
Variability in Response
8%
VKORC1
33%
Warfarin
12%
INIS
anticoagulants
7%
aspirin
7%
carboxylesterases
50%
comparative evaluations
7%
control
7%
data
7%
devices
100%
genes
28%
genetics
100%
genotype
28%
heart failure
71%
information
14%
management
7%
metabolism
14%
mortality
7%
nucleotides
7%
patients
100%
quality of life
7%
reduction
7%
risks
7%
shear
21%
therapy
35%
thrombosis
21%
Medicine and Dentistry
Antithrombotic Therapy
16%
Assisted Circulation
50%
Bleeding
16%
Coagulopathy
8%
DNA Polymorphism
8%
Genetic Polymorphism
100%
Genotype
8%
Heart Failure
25%
Heredity
8%
Left Ventricular Assist Device
50%
Quality of Life
8%
Thrombocyte Function
8%
Thromboelastography
16%
Thrombosis
16%